Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, Posterior uveitis, and Pan uveitis), By Cause (Infectious, and Non Infectious), By Condition (Acute, Chronic, and Recurrent), By Drug (Corticosteroids, Immunosuppressants, Monoclonal antibodies, Cycloplegic agents and others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

Uveitis is a combined condition of inflammation and swelling of the eyes. Uvea comprises of three parts Iris, ciliary body (small ring shape muscles behind iris and choroid), and choroid (it is the layer of tissue between retina and sclera), which decides eye color and helps eye in focusing and absorbing light. Uveitis can be caused by eye problems, autoimmune disease, HIV, multiple sclerosis, reactive arthritis, Kawasaki disease tuberculosis, and syphilis. Uveitis can affect people between the ages of 16 to 60 years, sometimes it may lead to permanent loss of vision. According to the National Center for Biotechnology Information (NCBI), uveitis counts for 10% to 15% of overall blindness. Treatments available for of uveitis include steroids, immunosuppressant, and monoclonal antibodies. Surgeries are performed in rare cases. Various pharmaceutical companies are working on R&D to launch new and effective medication for the treatment of uveitis, which is expected to boost the uveitis market.

Uveitis treatment market taxonomy

By Indication

  • Anterior uveitis
  • Intermediate uveitis
  • Posterior uveitis
  • Pan uveitis

By Cause

  • Infectious
  • Non infectious

By Condition

  • Acute
  • Chronic
  • Recurrent

By Drug

  • Corticosteroids
  • Immunosuppressant
  • Monoclonal antibodies
  • Cycloplegic agents
  • Antibodies
  • Antiviral
  • Antifungals
  • Analgesics

Research and development fuels the growth of uveitis treatment market

Several companies such as Pfizer Inc., pSivida Corp., and Novartis AG  are investing in R&D to produce novel drug for the treatment of uveitis. There are few drugs already in pipeline such as Sirolimus, dexamethasone phosphate, rituximab, which will boost the uveitis treatment market. Increase in demand of generic drugs is also expected to support the growth of uveitis treatment market. Uveitis are caused by infections such as cat-scratch disease, herpes zoster, and ulcerative colitis. According to NCBI report, 17.4 to 52.4 cases per 100000 person every year takes place and it causes 2.8 -10% of legal blindness in the U.S annually. Corticosteroids are the most commonly used treatment for uveitis as compared to other drugs such as biologics, immunosuppressant. After corticosteroids antibiotics and monoclonal antibodies are mostly used for the treatment.  Side effects of medication such as blurred vision, weight gain, insomnia, and increased appetite could be the major restraint for the growth of the uveitis market. Lack of awareness in emerging economies  can lead to chronic eye disease and vision loss.

Developed regions are major growth engines of the uveitis treatment market

Market comprises of regions that is North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. North America is the largest region and emerging market for uveitis treatment globally. Europe is the second largest emerging market which support the growth of global uveitis treatment market. After Europe, Asia pacific is the third largest growing market which includes emerging countries like India and China, owing to the increase in healthcare facilities and awareness people among the people, which will support the growth of uveitis treatment market.

Key players and major acquisitions to support the growth of uveitis treatment market

Key players operating global uveitis market include Allergan, Novartis AG, Valeant Pharmaceuticals International, AbbVie Inc., Eyegate Pharmaceuticals Inc., and pSivida corp. Allergan, Novartis and Valeant Pharmaceuticals International, Inc. are most dominant players in the market. Major acquisition takes place in this market include

  • In 2016, Allergan acquired a gene therapy company name Retrosome Therapeutics, which strengthen their ophthalmology drug pipeline. In the same year Allergan launched uveitis drug Taytulla.
  • In 2016, Novartis acquired Encore vision, which help to enhance their ophthalmology drug pipeline
  • In 2015, Eyegate signed a licensing agreement with valeant for effective combination of drugs for uveitis and in 2016 they acquired Jade Therapeutics Inc.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.